Skip to main content
SIU Annual Conference Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench-to-Bedside
Bench-to-Bedside
SIU@U
SIU@U

    Richard J. Bryant

    Associate Professor of Urology
    University of Oxford, United Kingdom

    I am Professor of Urology at the Nuffield Department of Surgical Sciences (NDS), and an Academic Director of the NDS Surgical Intervention Trials Unit (SITU), at the University of Oxford, and a Honorary Consultant Urologist, and current Urology Clinical Lead, at Oxford University Hospitals NHS Foundation Trust. I am Chief Investigator and co-Lead of the TRANSLATE (TRANSrectal biopsy versus Local Anaethetic Transperineal biopsy in Evaluation of clinically significant prostate cancer) randomised clinical trial (RCT), and I am the Chief Investigator of the currently-recruiting PART (Partial prostate Ablation versus Radical Therapy) RCT. I have been a Cancer Research UK / Royal College of Surgeons of England Clinician Scientist Fellow, and was Lead Clinician for the VANCE (VAcciNation in prostate CancEr) Clinical trial in Oxford. These academic, clinical and managerial roles have enabled me to combine my care of prostate cancer patients with a wide and growing prostate cancer research portfolio, covering the breadth of basic science, translational, and clinical research, at the University of Oxford. I also deliver undergraduate teaching in surgery and urology to clinical medical students.
    I undertook my undergraduate medical training at the University of Sheffield, where I completed an intercalated BMedSci(Hons) degree in pathology in 1995, and qualified with MBChB(Hons) in 1998. After completing Basic Surgical Training in South Yorkshire in 2003, I was awarded a Medical Research Council Fellowship (2004-2007) and undertook a PhD researching molecular mechanisms of prostate cancer progression. I then undertook higher surgical training in Urology in both Sheffield and Oxford, whilst in parallel continuing to pursue my prostate cancer research interests, leading to numerous scientific publications in this field. I continue to combine prostate cancer clinical practice and research, specialising in the diagnosis and management of this malignancy.

    Presentation(s):